ADVANCED SOLID CANCERS
Clinical trials for ADVANCED SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug ADCX-020 enters first human tests
Disease control Recruiting nowThis early-phase study tests a new cancer drug called ADCX-020 in 290 adults with advanced solid tumors that have not responded to standard treatments. The drug is an antibody drug conjugate designed to target and kill cancer cells. The study first finds the safest dose, then tes…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Immune cell duo takes on tough tumors in early trial
Disease control Recruiting nowThis study tests a new treatment that combines two types of immune cells—dendritic cells and CAR-T cells—to fight advanced solid cancers like stomach, colon, and pancreatic cancer. The goal is to see if this combination is safe and can shrink tumors. About 10 adults will take par…
Matched conditions: ADVANCED SOLID CANCERS
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 07:21 UTC
-
New cancer drug BNT329 enters human trials for Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new drug, BNT329, in people with advanced solid cancers that have a specific marker called CA19-9. The main goals are to check safety and find the best dose. About 245 participants will take part. The study also looks at whether the drug can shrink tumors or sl…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New antibody drug targets advanced cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests a new drug, PRL3-zumab, in 52 adults with advanced solid tumors that have not responded well to prior treatments. The drug is given every two weeks by IV. The main goal is to see how long the cancer stays under control and whether the drug is safe. This is not a …
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE2, PHASE3 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC